NRCHealthcare · Health Information ServicesThe 1 Wall Street analysts covering NRC Health hold a median 12-month price target of $27 — -0.3% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 90 of 100 as at 3 Nov 2026 — among the strongest tenth. The factors read stronger than the Street's target implies. That gap is the story on this page.
Consensus tells you what everyone already believes. The model scores NRC Health on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Momentum (99): The shares have been drifting up relative to others.
Growth (40): Sales and profits are flat, shrinking, or growing more slowly than they were.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
The bullish and bearish analyst opinions on NRC, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits −0.3% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 28 Oct 2026 | Citizens | Maintains | Market Outperform | $26 → $27 |
| 29 July 2026 | Citizens | Maintains | Market Outperform | — |
| 29 July 2026 | Citizens | Maintains | Market Outperform | $23 → $26 |
| 22 June 2026 | Citizens | Initiates | Market Outperform | $23 |
| 22 June 2026 | Citizens | Initiates | Market Outperform | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
NRC appears in the Radar on the weeks it earns a place.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and serversIn full
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 4 Nov 2026, NRC Health returned +104.4% against +14.8% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 8% of US stocks
Cheaper than 33% of US stocks
Cheaper than 2% of US stocks
Cheaper than 15% of US stocks
Higher than 55% of US stocks
Higher than 53% of US stocks
Higher than 75% of US stocks
Higher than 82% of US stocks
Higher than 58% of US stocks
Higher than 99% of US stocks
Higher than 92% of US stocks
Higher than 84% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
NRC Health has a market value of $510.8M and an enterprise value of $614.1M.
Revenue in the twelve months to 30 June 2026: $140.0M. The latest quarter grew 11.0% year on year.
Net income over the same four quarters: $5.9M, a 4.2% net margin.
Diluted earnings per share, trailing twelve months: $0.25.
Free cash flow in the twelve months to 30 June 2026: $21.6M.
NRC Health spent $18.8M on share buybacks and $12.7M on dividends in the twelve months to 30 June 2026.
Trailing P/E: 88.9×; forward P/E: 22.6× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 2.66%, paying out 250% of earnings.
NRC Health employs 357 people — $392K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own NRC Health — and when they’d sell — is the membership. See the Ticker Nerd 20 →
National Research, operating as NRC Health, reported third-quarter revenue growth of 11% to $38 million. A large customer implementation went live on schedule and contributed revenue for the full quarter.
Why it matters — The report links NRC Health’s quarterly revenue growth to the on-schedule launch and full-quarter contribution of a large customer implementation.
NRC Health announced its third-quarter 2026 results, reporting revenue growth of 11% year over year and sequential margin expansion. The company said a large customer went live on schedule and several long-standing customers renewed multi-year agreements.
Why it matters — The update highlights quarterly growth, margin expansion, and customer renewals relevant to tracking NRC Health’s performance and recurring-revenue base.
NRC Health announced the launch of nQuire Pro, a conversational analytics tool intended to help healthcare organizations expand their ability to understand patient-experience feedback, identify performance trends, and find improvement opportunities.
Why it matters — NRC watchers may note the launch as an extension of the company’s patient-experience offerings.
NRC Health’s latest nSight report, based on an analysis of data from 376, says high-performing health systems stand out by how effectively they turn patient feedback and experience data into action, rather than by how much information they access.
Why it matters — The report highlights NRC Health’s research on how healthcare organizations use patient experience data to inform action.
Zacks Investment Research published an analysis noting that NRC Health is trading at a discount while highlighting its rising recurring contract value, expanding sales pipeline, and AI-enabled tools. The report points to these factors as supporting revenue visibility and potential margin improvement.
Why it matters — An NRC watcher would care because the piece points to the company's recurring revenue growth, pipeline expansion, and AI capabilities as drivers of revenue visibility and potential margin improvement.
The 1 Wall Street analysts covering NRC Health have a median 12-month price target of $27, with estimates ranging from $27 to $27. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 1 analysts covering NRC Health, 1 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks NRC Health 90 out of 100 across roughly 4,600 US stocks as at 3 Nov 2026. None of this is personal advice — it does not consider your circumstances.
As at 3 Nov 2026, NRC Health ranks 90 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Momentum (99 of 100).
No one can know that. What the data says: the median 12-month target from 1 analysts implies -0.3% from the last close, and Ticker Nerd's factor model ranks NRC Health 90 out of 100 as at 3 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering NRC Health publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for NRC are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $27 to $27 over the next 12 months.
NRC Health returned +104.4% over the 12 months to 4 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
NRC Health is a healthcare experience management company headquartered in Lincoln, Nebraska. It provides software, analytics, and recurring service programs that help hospitals, health systems, medical groups, and other care organizations understand and improve the experiences of patients, consumers, and employees.
The most recent item we track (MarketBeat, 27 Oct 2026): "National Research Q3 Earnings Call Highlights". National Research, operating as NRC Health, reported third-quarter revenue growth of 11% to $38 million. A large customer implementation went live on schedule and contributed revenue for the full quarter.
NRC Health is a healthcare experience management company headquartered in Lincoln, Nebraska. It provides software, analytics, and recurring service programs that help hospitals, health systems, medical groups, and other care organizations understand and improve the experiences of patients, consumers, and employees. The company’s current offerings include patient experience measurement, consumer and market insights, online reputation management, employee engagement tools, and governance support for healthcare leaders. NRC Health also delivers benchmarking, segmentation, and workflow solutions designed to help organizations track perceptions, identify service gaps, and align care delivery with community needs. Its platform is used across the healthcare industry to support patient engagement, loyalty, workforce experience, and performance improvement through data-driven insight and human-centered care.
CEO Mr. Trent S. Green · 357 employees · United States · https://www.nrchealth.com
